Events Partner Content 2nd Digital Exosome Based Therapeutic Development Summit Advancing the Success of Exosome Therapeutics
Partner Content Partner Content Attendee List Released for SMi’s 9th Annual RNA Therapeutics RNA Therapeutics
Partner Content Partner Content The first patient to be injected with an RNA based anti-canc... RNA Therapeutics
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
